Biotechnology Assets Market Cap

Biotechnology Assets has a market cap or net worth of €16.79 million as of June 26, 2026. Its market cap has decreased by -20.23% in one year.

Market Cap

16.79M

Enterprise Value

17.75M

Revenue

3.43M

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.23

Market Cap Chart

Since May 29, 2018, Biotechnology Assets's market cap has decreased from 74.66M to 16.79M, a decrease of -77.51%. That is a compound annual growth rate of -16.86%.

Market Cap History

Date	Market Cap	% Change
Jun 26, 2026	16.79M	17.63%
Dec 31, 2025	14.27M	-21.93%
Dec 31, 2024	18.28M	-20.03%
Dec 29, 2023	22.86M	84.02%
Dec 30, 2022	12.42M	-40.67%
Dec 30, 2021	20.94M	-3.86%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
May 29, 2018	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Grifols	5.56B
Laboratorios Farmaceuticos Rovi	3.00B
Almirall	2.42B
Faes Farma	1.44B
Oryzon Genomics	246.49M
Prim, S.A.	227.98M
Laboratorio Reig Jofre	219.00M
Atrys Health	195.84M

Market Cap Rankings